ClinicalTrials.gg

Zai Lab Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 32 studies whose lead sponsor is Zai Lab Limited or one of 3 companies grouped under it. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 4, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Zai Lab with Hoffmann-La Roche and Amgen →

Pipeline: 4 programs

Each counted once: 4 with a study Zai Lab Limited leads registered in the last two years.

  • Phase 1
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Zai Lab Limited’s own registered studies; Zai Lab Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Zai Lab Limited’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

5 of Zai Lab Limited’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. 1M
  6. A
  7. 1M
  8. J
  9. J
  10. 2A
  11. S
  12. O
  13. N

Add all 5 to your calendar (.ics) → With an account.

All 32 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now928%Recruiting 6 · Not yet recruiting 3
  • Under way, not recruiting26%
  • Completed1134%
  • Stopped early619%
  • Status unknown or other413%

Phase

  • Phase 117
  • Phase 29
  • Phase 37

Where

  • China26
  • United States7
  • Spain3
  • Australia3
  • New Zealand2
  • Taiwan1

Over the years

  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 920
  7. 21
  8. 22
  9. 23
  10. 24
  11. 25
  12. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Zai Lab Limited.

  • Zai Lab (Shanghai) Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies →
  • Zai Lab (Hong Kong), Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Zai Lab Pty. Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies
  • Zai Biopharmaceutical (Suzhou) Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 32 of 32.